Full name
NSZOZ KARDIOLOGIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.22.Z - Specialist medical practice
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
86.1 - Hospital activities
86.2 - Medical and dental practices
86.9 - Other healthcare activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -26,3 | 63 | -2 | -103,2 |
EBITDA | 2 | 65,2 | -0,5 | -100,7 |
Short time liabilities | 45,6 | 26,3 | 22 | -16,2 |
Income tax | 0 | |||
Equity capital | -0,5 | 59,2 | 57,1 | -3,4 |
Operating profit (EBIT) | -26 | 65,2 | -0,5 | -100,7 |
Assets | 45,1 | 105,6 | 92,9 | -12 |
Net profit (loss) | -26,3 | 59,7 | -2 | -103,4 |
Net income from sale | 387,4 | 611,1 | 671,1 | 9,8 |
Liabilities and provisions for liabilities | 45,6 | 46,5 | 35,8 | -23 |
Working assets | 45,1 | 105,6 | 92,9 | -12 |
Depreciation | 28 | 0 | 0 | 0 |
Basic operational activity income | 15,4 | |||
% | % | % | p.p. | |
Profitability of capital | 5070,2 | 100,9 | -3,5 | -104,4 |
Equity capital to total assets | -1,2 | 56 | 61,5 | 5,5 |
Gross profit margin | -6,8 | 10,3 | -0,3 | -10,6 |
EBITDA Margin | 0,5 | 10,7 | -0,1 | -10,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 43 | 16 | 12 | -4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane